Pharma-Bio Serv (PBSV) Depreciation & Amortization (CF) (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Depreciation & Amortization (CF) came in at $13640.0 in Q2 2026, down 27.7% on a YoY basis from $18866.0 in Q2 2025, and down 7.81% quarter-over-quarter from $14796.0 in Q1 2026.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $13640.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Depreciation & Amortization (CF) fell 27.7% year-over-year to $13640.0; the trailing twelve-month figure through Apr 2026 stood at $59997.0 (up 54.54% YoY), and the FY2025 full-year result was $59866.0, up 156.81% from the prior year.
- Depreciation & Amortization (CF) fell to $13640.0 in Q2 2026 per PBSV's latest filing, from $14796.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $18866.0 in Q2 2025 and bottomed at $4589.0 in Q3 2024.
- Historically, Depreciation & Amortization (CF) has averaged $11711.4 across 5 years, with a median of $12881.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) slumped 59.75% in 2024, then jumped 243.08% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $12800.0 in 2022, then slumped by 42.25% to $7392.0 in 2023, then decreased by 19.81% to $5928.0 in 2024, then surged by 166.82% to $15817.0 in 2025, then slipped by 13.76% to $13640.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $13640.0, $14796.0, and $15817.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | - |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 46.00 Mn |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 45.18 Mn |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 14.77 Mn |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 45.00 Mn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | - |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 21.59 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | 12.28 Mn |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 8.69 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 13,640.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 13,640.00 |
| Jan 31, 2026 | 14,796.00 |
| Oct 31, 2025 | 15,817.00 |
| Jul 31, 2025 | 15,744.00 |
| Apr 30, 2025 | 18,866.00 |
| Jan 31, 2025 | 9,439.00 |
| Oct 31, 2024 | 5,928.00 |
| Jul 31, 2024 | 4,589.00 |
| Apr 30, 2024 | 5,508.00 |
| Jan 31, 2024 | 7,286.00 |
| Oct 31, 2023 | 7,392.00 |
| Jul 31, 2023 | 11,400.00 |
| Apr 30, 2023 | 13,167.00 |
| Jan 31, 2023 | 16,127.00 |
| Oct 31, 2022 | 12,800.00 |
| Jul 31, 2022 | 12,962.00 |
| Apr 30, 2022 | 12,140.00 |
| Jan 31, 2022 | 13,205.00 |
| Oct 31, 2021 | 14,290.00 |
| Jul 31, 2021 | 18,183.00 |